Haya Therapeutics

Haya Therapeutics

Haya Therapeutics develops RNA-targeting therapies for fibrosis and related diseases.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $65M

About

Haya Therapeutics develops RNA-targeting therapies for fibrosis and related diseases.

RNA TherapeuticsCardiovascularFibrosis

Funding History

1
Total raised:$65M
Venture$65M